STAT

‘I was a 31-year-old kid in a way’: How a cancer diagnosis changed a health care reporter

Alexandra Glorioso of Politico talks about what it’s like to report on health care while undergoing treatment for breast cancer.

All health care reporters deal with the medical system outside of work. But not many of them have dealt with it like Alexandra Glorioso has in recent months.

Glorioso is a reporter for Politico. She’s based in Tallahassee, Fla., and she writes about health care, insurance, and the state legislature. She covers stories like the push to expand Medicaid in Florida and legislative proposals to rein in drug costs.

Last summer, at age 31, Glorioso was diagnosed with stage 2 breast cancer. She underwent chemotherapy, participated in a clinical trial with an experimental drug, and had surgery. Then, in March, she announced she was in remission, with no evidence of disease. This week, Glorioso talked with STAT about what the whole experience has been like — and how it shaped her thinking as a health care reporter.

How are you doing and what kind of treatment are you currently undergoing? 

It has been a really weird experience, actually, entering remission, because I thought my life would get easier after that. But it

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related Books & Audiobooks